Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Taiwan Stock Exchange (TWSE) is the principal stock exchange of Taiwan, headquartered in the Taipei 101 building in Taipei. Established in 1961, it provides a comprehensive platform for the listing and trading of various financial instruments, including stocks, bonds, and exchange-traded funds. While the TWSE is a financial services institution rather than a life sciences company, it serves as a vital funding source for Taiwan's robust biotechnology and pharmaceutical sectors. The exchange operates under the regulatory oversight of the Financial Supervisory Commission and is responsible for maintaining market integrity and transparency. It manages the TAIEX, the most widely followed index of Taiwan's equity market performance, and facilitates the growth of high-tech industries by connecting them with domestic and international investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan Stock Exchange.